Vimarsana
Biggest News Aggregation in the World

Sunbeam Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sunbeam Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sunbeam Corp Today - Breaking & Trending Today

Job layoffs, AI and the capitalist model we need to refashion - Vimarsana News

Job layoffs, AI and the capitalist model we need to refashion

A system skewed towards rewarding corporate leaders for cutthroat efficiency exacts a terrible price on workers and society at large. Read more at straitstimes.com.

Newell closing Coleman plastics plant in Texas - Vimarsana News

Newell closing Coleman plastics plant in Texas

Newell Brands Inc. is closing its Coleman Co. Inc. camping products plant in New Braunfels, Texas, eliminating 144 jobs by year's end.

Michael Price, Who Saw Value in Companies' Struggles, Dies at 70 - Vimarsana News

Michael Price, Who Saw Value in Companies' Struggles, Dies at 70

Price boasted one of the best records in mutual fund management in the 1980s and 1990s/

Securities Litigation Update: Federal Courts Allow Section 10(b) Claims Based on Non-Fraudulent "Channel Stuffing" and Hyped COVID-19 Vaccine Candidate | Cadwalader, Wickersham & Taft LLP - Vimarsana News

Securities Litigation Update: Federal Courts Allow Section 10(b) Claims Based on Non-Fraudulent "Channel Stuffing" and Hyped COVID-19 Vaccine Candidate | Cadwalader, Wickersham & Taft LLP

Federal courts closed out 2021 with a flurry of securities decisions in the month of December.  In this update, we discuss two decisions involving claims under Section 10(b) of the...

Discussing Securities Litigation Update - Vimarsana News

Discussing Securities Litigation Update

We discuss two decisions involving claims under Section 10b of the Securities Exchange Act of 1934 and Rule 10b-5 based on alleged channel stuffing a company’s practice of shipping excessive product to its distributors, and an allegedly over-hyped COVID-19 vaccine candidate.